Last reviewed · How we verify

NCT04867460: TUFF

Ultrasound-guided Venous Access for Pacemaker and Defibrillator Implants

Terminated NA Last updated 4 March 2025
What this trial tests

NA trial testing Ultrasound guided venous access in Cardiac Arrhythmia in 58 participants. Terminated before completion.

Timeline
1 April 2021
Primary endpoint
27 February 2025
27 February 2025

Quick facts

Lead sponsorRegion Skane
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment58
Start date1 April 2021
Primary completion27 February 2025
Estimated completion27 February 2025
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

18 and older, any sex, with Cardiac Arrhythmia or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will include patients scheduled for transvenous pacemaker- or implantable defibrillator surgery, where venous access is necessary for lead implantation. A 1:1 randomization will be performed to either standard access (at the discretion of the surgeon) or ultrasound-guided using a wireless vascular transducer (Siemens Freestyle). Primary outcome is mean time to vascular access. In addition, success rate, complication rate and total procedure time will be measured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound guided venous access

Trials testing the same drug.

Other recruiting trials for Cardiac Arrhythmia

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04867460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing